A detailed history of Marshall Wace, LLP transactions in Paragon 28, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 30,822 shares of FNA stock, worth $319,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,822
Holding current value
$319,315
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.32 - $9.03 $194,795 - $278,322
30,822 New
30,822 $205,000
Q2 2023

Aug 14, 2023

SELL
$16.64 - $18.88 $2.43 Million - $2.76 Million
-146,099 Reduced 71.16%
59,208 $1.05 Million
Q1 2023

May 15, 2023

BUY
$15.89 - $21.05 $3.26 Million - $4.32 Million
205,307 New
205,307 $3.5 Million

Others Institutions Holding FNA

About Paragon 28, Inc.


  • Ticker FNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 76,775,800
  • Market Cap $795M
  • Description
  • Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navic...
More about FNA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.